D. Peters

发表

Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.

R. Davis, D. Peters, D. McTavish, 1994, Drugs.

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

D. Faulds, G. Plosker, D. Peters, 1993, Drugs.

Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure.

D. Peters, J. Frampton, 1995, Drugs.

Satumomab Pendetide

D. Peters, A. Fitton, 1995, Clinical Immunotherapeutics.

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

D. Peters, S. Clissold, David H. Peters, 1992, Drugs.

Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

D. Peters, D. McTavish, H. A. Friedel, 1992, Drugs.

Fludarabine

A. Markham, D. Peters, J. Adkins, 2012, Drugs.

Finasteride

D. Peters, E. Sorkin, David H. Peters, 1993, Drugs.

Cetirizine : A Reappraisal of its Pharmacological Properties and Therapeutic Use in Selected Allergic Disorders.

D. Faulds, D. Peters, C. Spencer, 1993, Drugs.

Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

R. N. Brogden, D. Peters, 1994, Drugs.

Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease.

K. Goa, D. Peters, D H Peters, 1995, Drugs.

Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

R. N. Brogden, D. Peters, 1994, Drugs.

Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

D. Peters, J. Balfour, P. A. Todd, 1995, Drugs.

Metoprolol

D. Peters, P. Benfield, P. Benfield, 1994, PharmacoEconomics.

Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy.

D. Peters, E. Sorkin, 1993, Drugs.

Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.

D. Faulds, D. Peters, J. Adkins, 1997, Drugs.

Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

D. Peters, H. Bryson, C. Rains, 1995, Drugs.

Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.

D. Peters, C. Dunn, 1995, Drugs.

Loratadine

D. Peters, M Haria, A Fitton, 1994, Drugs.

Tiapride

D. Faulds, D. Peters, D H Peters, 1994, Drugs.

Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma.

D. Faulds, D. Peters, 1995, PharmacoEconomics.

Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders.

D. Peters, A. Fitton, M. Haria, 1994, Drugs.

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders.

D. Faulds, D. Peters, C. Spencer, 1993, Drugs.

Erratum to Teicoplanin: a reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

R. N. Brogden, D. Peters, 2012, Drugs.

Erratum to Teicoplanin: a reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

R. N. Brogden, D. Peters, 1994, Drugs.

Tiapride: A Review of its Pharmacology and Therapeutic Potential in the Management of Alcohol Dependence Syndrome

D. Faulds, D. Peters, 1994 .

Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

R. N. Brogden, D. Peters, 1994, Drugs.